VGI Health Technology (XNEC:VTL) Interest Expense : A$ Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. VGI Health Technology's interest expense for the six months ended in . 20 was A$ 0.00 Mil. VGI Health Technology does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. VGI Health Technology's Operating Income for the six months ended in . 20 was A$ 0.00 Mil. VGI Health Technology's Interest Expense for the six months ended in . 20 was A$ 0.00 Mil. VGI Health Technology did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

VGI Health Technology Interest Expense Historical Data

The historical data trend for VGI Health Technology's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Interest Expense Chart

VGI Health Technology Annual Data

Trend

Interest Expense

VGI Health Technology Semi-Annual Data

Interest Expense

VGI Health Technology Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

VGI Health Technology (XNEC:VTL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

VGI Health Technology's Interest Expense for the six months ended in . 20 was A$0.00 Mil. Its Operating Income for the six months ended in . 20 was A$0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was A$0.00 Mil.

VGI Health Technology's Interest Coverage for the quarter that ended in . 20 is calculated as

VGI Health Technology had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines